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Platelets  are blood  elements  that  play a  key role  in  coagulation  and  participate 
directly  in  the  processes  of  thrombosis  and  atherosclerosis  (1-3).  However,  the 
physiologic mechanisms governing platelet  formation and  release from megakaryo- 
cytes remain largely unknown (4). Platelets are nonnucleated cells with only a vestigial 
protein  synthetic  apparatus,  and  therefore  most  of the  structural  and  functional 
components associated with platelets are believed to be derived from megakaryocytes. 
Thus,  a  better understanding  of megakaryocyte biology should  provide important 
new  insights  into the mechanisms of platelet production  and into the expression of 
the  various  aspects  of platelet  function  during  thrombopoiesis.  Since  Wright  first 
hypothesized the megakaryocyte-platelet relationship over 70 yr ago (5), most of the 
information concerning megakaryocytes has been obtained indirectly from studies of 
patients  with  platelet-associated  bleeding  disorders  or  experimental  animals  with 
artificially altered platelet levels (1, 6-8). Recently, techniques have been reported to 
obtain partially purified populations of megakaryocytes from mouse, rat, and guinea 
pig marrow tissue  (9-11).  With  these preparations,  various platelet-associated com- 
ponents  have  been  identified  in  nonprimate  megakaryocytes  (12,  13).  Moreover, 
culture systems have now been devised to grow and examine murine megakaryocytes 
in vitro (14,  15). 
In studies of the differentiation of other types of hematopoietic cells, cell component 
analysis has proven a  valuable tool both for monitoring the degree of differentiation 
and  for identifying  the  distinct  types of progenitor  cells  (16-18).  It  is  known  that 
individual platelets are heterogenous in their density, size, and function  (19, 20), but 
it  has  yet  to  be  determined  whether  these  diversities  arise  as  a  result  of platelet 
formation occurring at different stages of megakaryocyte maturation or, alternatively, 
whether  they  arise  because  of  the  existence  of separate  and  distinct  committed 
progenitor cells that  generate  different  platelet  subsets.  By analogy to other hemo- 
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poietic cell lineages, analysis of megakaryocyte cell components may elucidate the 
mechanisms of megakaryocyte maturation and the development of platelet functions. 
In this report, studies were directed toward defining several of the membrane and 
cytoplasmic elements of human  megakaryocytes.  After  a  method  was  devised  for 
isolating pure populations of human megakaryocytes with high yield, the presence of 
various platelet-associated components was examined by immunofluorescence. Fibrin- 
ogen, plasma factor VIII antigen (factor VIII:AGN),  1 platelet myosin, and platelet 
glycoproteins I and III were detected in over 90% of human marrow megakaryocytes. 
Furthermore,  parallel  analysis  of  both  human  and  murine  megakaryocytes  and 
platelets for  Fc  receptor,  complement receptors,  and  Ia  antigens revealed  that  the 
expression of these ceil components may be useful markers for monitoring megakar- 
yocyte maturation. 
Materials and Methods 
Preparation of Human  Bone  Marrow  Cell  Suspension.  Bone  marrow  was  obtained from  ribs 
routinely removed  from  individuals undergoing thoracotomy.  Written consent  from  each 
individual studied was  obtained according to  the  regulations established by  the  National 
Institutes of Health, and protocols were approved by the Committee on Human Rights. Ribs, 
rather than bone marrow aspirates, were chosen as the source of marrow tissue  because ribs 
contained a larger number of marrow cells and little, if any, blood cell contamination. Marrow 
cells were harvested promptly after the ribs were removed. Ribs cleaned of adherent tissues 
were cut into fragments of 2-4 cm in length with a  bone cutting forceps.  Marrow cells were 
harvested by injecting medium very gently into the central cavity of the bone, forcing out the 
marrow tissue. Subsequently,  the rib fragments were opened with a bone rongeur and additional 
tissue was  flushed out  from  the  inner face  of the  bone walls.  A  single cell  suspension was 
obtained by either gently forcing the cells through a  23-gauge needle or by gently pipetting 
with a Pasteur pipette. Each 2- to 5-cm section obtained from the anterior third of a rib usually 
provided 1-2  ×  108 cells/cm for a total of 5-13  ×  l0  s marrow cells per rib sample. Selective 
cell  loss during this procedure was  ruled out by careful histological examination of the rib 
segments before and after harvesting the  marrow. The medium (CATCH)  used  to  harvest 
marrow cells was derived from the formula described by Levine and Fedorko (9): Calcium and 
magnesium-free Hanks' balanced salt solution (Grand Island Biological Co., Grand Island, N. 
Y.) containing 10  -3 M adenosine, 2  ×  10  -3 M theophylline, 3.8% sodium citrate, 3.5% bovine 
serum albumin (BSA), 20-40 U/ml of highly purified DNase, and 25 mM Hepes buffer, pH 
7.0  ±  0.2  (all from Sigma Chemical Co., St.  Louis, Mo.). The modification consisted of the 
addition of DNase  and  Hepes  buffer.  Cells  were  washed  once  and  then  resuspended  for 
determination of cell number, differential, and cell viability. Cell viability was estimated by 
trypan blue exclusion and structural examination by phase contrast microscopy. 
Density  Separation of Human  Bone Marrow  Cells.  The cell  density profile of megakaryocytes 
and other human marrow cell types was determined by centrifugation in density gradients of 
either BSA (preservative-free 35% BSA wt/wt) or colloidal silica coated with polyvinylpyrroli- 
done, Percoll (Pharmacia Fine Chemical, Piscataway, N. J.)  (21). Solutions were diluted in 
CATCH medium buffered with 25 mM Hepes, pH 7.0. All fractions had a final pH of 7.0 and 
osmolarity of 290 mOsmo. Cell density determinations were performed either with a series of 
several different tubes, each  containing a  single density step,  or by discontinuous gradient 
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centrifugation (22). For the first  procedure, up to 8  ×  107 cells were resuspended in 5 ml of 
medium of the  appropriate  density and  placed  into a  17  ×  100-mm polypropylene tube 
(Falcon Plastics, Div. of BioQuest Oxnard, Calif.). The cell suspension was then underlayered 
with 5 ml of medium of higher density and centrifuged at  1,000  g for either 20, 30, or 45 min 
at 20 °  +  2°C using a swing-out rotor. As it was found that the time of centrifugation did not 
influence the degree of separation, 20 min was used for all experiments. Cells recovered from 
the supernate and pellet were analyzed for both number and differential. 
For discontinuous gradient  centrifugation, a  similar type  of analysis was  performed  by 
layering marrow cells on top of multiple density layers of either BSA or Percoll.  Marrow cell 
suspensions were distributed into various groups of 17  ×  100-mm siliconized glass tubes, 5 ml/ 
tube. Cells were underlayered in succession  with three 5-ml layers of medium of increasing 
density. Several groups of tubes received layers that covered a wide range of densities (1.020- 
1.12 g/cm  a BSA or Percoll).  Gradients were pumped beneath the cell suspension with a syringe 
pump (model 351, Sage Instruments Div., Orion Research Inc., Cambridge, Mass.)  connected 
to capillary tubing that extended to the bottom of each tube. The specific gravity of the BSA 
and Pereoll media was determined both by measuring the refractive index with an Abbe 3-L 
refractometer (Baush & Lomb Inc., Rochester, N.  Y.)  and direct weighing 100-ml vol of the 
various gradient media at  20 °  +  0.5°C. After preparation, the density media were passed 
through 0.45-/~m filters  and stored at 4°C. Before  use,  the media were warmed to 20°C and 
mixed extensively. 
Isolation of Megakaryocytes 
STEP  1.  PREPARATIVE DENSITY CENTRIFUGATION. Megakaryocytes  were  initially separated 
from the majority of marrow cells by a  BSA or Percoll bouyant density centrifugation step 
performed as follows:  (a)  7-8 ×  10  v marrow cells were resuspended in 3 ml CATCH medium 
containing either  1.062  g  BSA/cm  3 or  1.050 g  Percoll/cm  z and  placed  in  17  ×  100-mm 
polypropylene tubes; (b) cells were then underlayered with 3 ml CATCH medium containing 
1.085 g/era  3 BSA or Percoll and overlayered with 3 ml of medium containing 1.040 g/cm  ~ BSA 
or Pereoll, respectively. After centrifugation at 1,000  g for 20 min at 20°C, cells were harvested 
into three fractions. Fraction I comprised all the cells from the top gradient layer and the upper 
interface. Fraction II consisted of the cells from the intermediate gradient layer, and fraction 
III was made up of cells from the bottom gradient layer and the pellet. 
ST~P  2.  VELOCXTY SEDIMENTATION.  Megakaryocytes  were  further  purified  by  processing 
density gradient-derived fraction I by velocity sedimentation. A  12-ml continuous gradient of 
2-4% Ficoll (Pharmacia Fine Chemicals) in CATCH medium pH 7.0 containing 5% fetal calf 
serum (FCS)  was formed in 17  ×  100-em polypropylene tubes with a gradient maker.  10-40 
x  106 cells from fraction I, resuspended in 1 ml CATCH medium containing 5% FCS, were 
layered on top of the Ficoll gradient. To minimize any gradient interface effects, the cells were 
gently mixed with the uppermost region of the Ficoli gradient. After centrifugation at 100 g for 
5 min at  20°C, megakaryocytes were  harvested from the pellet fraction, whereas  the other 
marrow cells were spread throughout the gradient primarily according to cell size. The pellet 
fraction was then processed  in a second cycle of velocity sedimentation in a similar manner. 
The final megakaryocyte preparation with the highest purity was obtained from the second 
cycle pellet. 
Mouse MegakaoIocytes.  Mouse megakaryocytes were obtained from three different sources. 
These included fresh bone marrow tissue, long-term bone marrow cultures, and colony-forming 
unit megakaryocytes (CFU-M) grown in agar.  Marrow  megakaryocytes were isolated from 
(DBA/2 X C57BL/7) Fx mice by the same method described above for human megakaryocytes. 
Long-term liquid cultures of bone marrow cells were established by the technique of Williams 
et al. (15). Briefly,  to establish an adherent cell feeder layer, bone marrow, cells from a single 
femur were  expressed  directly into 25-cm  2 plastic  flasks  (Coming Medical,  Corning Glass 
Works, Medfieid, Mass.). The cells were incubated at 33°C in 10 ml of Fisher's medium (Grand 
Island Biological)  containing 20% horse serum (Flow Laboratories, Inc., Rockville, Md.). After 
either 3 or 4 d, half the medium containing half of the nonadherent cells was removed, and the 
cultures were fed with an equal volume of fresh medium. After 7 d, all the nonadherent cells 
were removed, and 3-5  X  106 freshly isolated bone marrow cells were added in new medium. 
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medium. The cells harvested at various times up until the 3rd or 4th wk of culture contained 
0.5-1% megakaryocytes and CFU-M. 
Mouse megakaryocytes were also derived from CFU-M cloned in semisolid agar culture with 
a  modification of the technique of Metcalf et al. (14). Cells from either femoral bone marrow 
or from liquid cultured marrow cells were plated at concentrations of 75,000 cells/ml in 35-mm 
Petri dishes (Falcon 3001,  Falcon Plastics) in McCoy's 5A modified medium containing 15% 
FCS and 0.25%  Bactoagar (Difco Laboratories, Detroit, Mich.)  supplemented with essential 
and nonessential amino acids, 200 mM glutamine, asparagine, sodium pyruvate, and  10  -4 M 
2-mercaptoethanol. Colonies were grown  in  the presence of both  an  obligatory stimulation 
factor and a potentiating activity. Megakaryocyte colony-stimulating activity was obtained by 
adding 100/~1 of conditioned medium from long-term marrow cultures of a WEHI-3 murine 
marrow  myelomonocytic leukemic  cell  line  (23).  Megakaryocyte-potentiating activity was 
obtained by adding 200 #1 of medium conditioned by the long-term culture of bone marrow 
cells (23).  Colonies of megakaryocytes were readily identified by the size of the majority of 
colony cells. Colonies were  generally irregular in  shape  and  had  <  50  cells. Cytochemical 
identification by both large and small megakaryocytes was made on isolated colony cells by 
staining for the presence of aeetylcholine esterase (24).  Colonies were individually harvested 
under microscopic visualization (× 40) with a Pasteur pipette, and placed into 400-#1 polypro- 
pylene tubes  (Milian  Instruments  SA, Geneva,  Switzerland)  containing CATCH  medium. 
Colony cells were freed from agar by repeated gentle pipetting and two washes in CATCH at 
500 g for 5 min. 
Preparation  of Washed Platelets.  Blood samples drawn  from  normal, healthy volunteers or 
C57B1/6 mice were mixed with 3.2% sodium citrate in polypropylene tubes. After centrifugation 
of the blood mixture at 255 g for  10 rain at room temperature, the supernatant platelet rich 
plasma was aspirated, the platelets were pelleted by centrifugation at  1,100 g for 20 min, and 
then washed three times with a 0.12 M  sodium chloride solution containing 0.0129 M  sodium 
citrate and 25 mM glucose pH 6.8 (25). Platelet counts were performed with a Coulter Counter 
model ZBI (Coulter Electronics Inc., Hialeah, Fla.). 
Immunofluorescence Assay.  Monospecific  rabbit  antisera  against  human  fibrinogen,  factor 
VIII:AGN, a2 macroglobulin, platelet myosin, platelet glycoproteins I and III, as well as human 
Ia antigen and human and mouse immunoglobulins, were prepared and tested for specificity 
as described (26-31). Mouse A.TH anti-A.TL (anti-Ia  k) serum was a generous gift from Dr. P. 
Kincade  of Sloan-Kettering Institute,  New  York,  and  full  discussion of its  preparation  is 
presented elsewhere (32).  After isolation of the IgG fraction from each antiserum by DEAE- 
cellulose chromatography (31), each antibody was treated with pepsin (Worthington Biochem- 
ical Corp., Freehold, N. J.) to produce F(ab')2 fragments (33). F(ab')2 fragments were separated 
from trace amounts of uncleaved IgG and pFc fragments by Sephacryl S-200 (Pharmacia Fine 
Chemicals) gel filtration. The F(ab')2 fragments were shown to be free of uncleaved IgG and 
pFc fragments by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and by immuno- 
diffusion analysis with  goat anti-rabbit Fc fragment-specific antiserum.  Occasionally, intact 
IgG antibody preparations were treated with soluble Staphylococcus aureus protein A (Pharmacia 
Fine Chemicals) in order to block functionally the Fc region of the IgG molecule (34). Effective 
blockage of the Fc region, without protein precipitation, was obtained by incubating protein A 
with IgG solutions at a  7:1 wt/wt ratio, first at 37°C for 2 h  and then at 40C overnight. For 
direct immunofluorescence, the IgG F(ab')2 fragments were conjugated to either fiuorescein 
isothiocyanate  (FITC)  or  tetramethylrhodamine  isothiocyanate  (TRITC)  (both  from  BBL 
Microbiology Systems, Becton, Dickinson & Co., Cockeysville, Md.) as described in more detail 
elsewhere  (31,  33).  In  some  instances,  indirect  immunofluorescence  was  performed,  using 
unlabeled rabbit antibody followed by the fluoresceinated F(ab')2 fragment of goat anti-rabbit 
IgG antibody. For fluorescence staining of membrane-restricted components, isolated mega- 
karyocytes (50-150  ×  10  a)  or platelets (1-2  ×  10  s) were incubated with 0.05-0.1  ml of the 
fluoresceinated antibody at room temperature for 30 min. Cells were then washed through a 3- 
ml layer of 20% BSA in CATCH medium. For indirect immunofluorescence, cells were treated 
with the first reagent, washed twice, and then incubated with 0.05-0.1 ml of the fluoresceinated 
goat anti-rabbit serum. Staining of cytoplasmic elements was carried out by incubating smears 
of megakaryocytes with  the  antibody preparations after fixing cells in  acetone  for  15  min 
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Ortholux II microscope (E. Leitz, Inc., Rockleigh, N. J.) equipped with Ploem illuminator and 
phase contrast. 
Complement Receptor Assay.  The two types of  complement ((2) receptors, complement receptor 
type one,  the immune adherence  ((24b-(23b)  receptor  ((2R1) and complement receptor type 
two, the (23d receptor ((2R2), were detected by rosette formation with sheep erythrocytes-rabbit 
IgM antibody-complement complexes (EA(2) prepared as described (35, 36). 
(2 receptor-dependent  rosettes were formed in  12  ×  75-mm polypropylene tubes  (Falcon 
Plastics)  by  mixing  together  0.1  ml  of EA(2  at  2  ×  l0  s  with  0.1  ml  of either  isolated 
megakaryocytes  (5-100  ×  103) or  platelets  (3-5  ×  109/ml)  resuspended  in  RPMI-1640 
(Microbiological Associates,  Bethesda, Md.)  followed by incubation on a  tube rotator for 15 
min at 37°(2 (35). Rosettes in the cell suspension were enumerated by phase contrast microscopy, 
or alternatively,  differential  counts of rosetted cells  were made from Wright-Giemsa stained 
smears. For staining, rosette mixtures were pelleted at  100 g for 2 min, resuspended in 20/~l of 
F(2S  and  immediately smeared  across microscopy slides  with  a  coverslip.  The smears  were 
quickly dried with a hair dryer and then stained with Wright-Giemsa. 
Detection of Fc Receptor (FOR).  FcR cell membrane receptors for the Fc portion of IgG, were 
detected either by rosette formation with sheep and (or) ox erythrocytes sensitized with rabbit 
IgG antibody (EAx#) or by fluorescence assay with soluble immune complexes conjugated to 
FIT(2 (37, 38). For the rosette assay, a mixture of 0.05-5.0  ×  105 megakaryocytes resuspended 
in 0.1 ml CATCH and 0.1 ml of EAI# at 2  X  10a/ml CATCH was incubated at 37°C for 15 
min, centrifuged at 200 g for 5 min, and reincubated at room temperature for 30-60 min. After 
gently resuspending the pellet, rosettes were enumerated either in suspension by phase contrast 
microscopy or in Wri~ht-Giemsa stained smears by bright-field microscopy. For the fluorescence 
assay, 0.05-5.0  ×  10  megakaryocytes or 5-10  ×  10  platelets were incubated for 30 rain at 
room temperature with soluble immune complexes prepared at antibody excess with either 25 
/~1 of rabbit IgG antikeyhole limpet hemocyanin (KLH) conjugated to FIT(2 and 25 ~1 of KLH 
conjugated to FITC, or 25 #1 of rabbit IgG antiovalbumin conjugated to FITC and 25/~1 of 
ovalbumin  conjugated to  FITC.  After three  washes  with  CAT(2H  medium,  the cells  were 
examined by fluorescence microscopy. 
Results 
Isolation  of Human  Megakaryocytes by Density  Gradient Centrifugation.  Human  mega- 
karyocytes  were  separated  from  the  majority  of other  marrow  cells  by  density 
centrifugation with either BSA or Percoll gradients. The density that maximized this 
separation  was first determined  in pilot studies in which the density distributions  of 
the various marrow cell types were analyzed in both density media (Fig.  1). Isolation 
of megakaryocytes was reproducibly better in Percoll than in BSA. By using BSA as 
a  density medium,  megakaryoeytes were found in all  fractions  (1.020-1.085  g/cm3). 
By contrast, with  Percoll gradients,  megakaryocytes were found only in low density 
fractions (1.020-1.050 g/era3). This difference in density characteristics was restricted 
to  megakaryocytes,  because  the  density  distribution  of other  cell  types  was  not 
significantly different in either media. 
When the cell  density distribution  of megakaryocytes was compared with  that  of 
other  marrow cell  types,  it  was  found that  about  57%  of megakaryocytes and  only 
15% of the other marrow cells contained a  density lower than  1.062 g/cm  3. BSA. By 
comparison,  a  considerably  better  enrichment  of megakaryocytes was  obtained  in 
Percoll. Over many experiments, >  90% of all megakaryocytes and --- 12% of all other 
marrow cells were less dense than  1.050 g/cm  3. 
Based  on this  distribution  analysis,  a  simplified  procedure  was  devised  for using 
either  Percoll or BSA as a  separating  medium.  Because  some megakaryocytes were 
found to be dense  in  BSA, a  procedure  involving three  densities  was established  as 
described in Materials and Methods. With BSA, the fraction with density lower than 1278 
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FIG.  1.  Density distribution  of human  megakaryocytes (shaded columns) and  other  marrow 
nucleated cells (open columns). Columns are the mean percent, and bars represent the SEM of at 
least four experiments in  which  the  yield was >  90%  of the  starting  cells. Fractionation  was 
performed either by combining several neutral density separation experiments with a single density 
step or by discontinuous gradient centrifugation with up to three density steps. 
1.062 g/cm  a contained about  90  ±  10  ×  10  a megakaryocytes that  represented  50% 
of the  starting  megakaryocyte  population  (Table  I).  Megakaryocytes  in  this  low 
density fraction contained ~  0.4% megakaryocytes representing a  10-fold enrichment 
over the starting sample.  Cells collected from fraction II had 0.08% megakaryocytes, 
a  twofold enrichment  over the  starting  sample.  The pellet  fraction  contained  only 
0.02% megakaryocytes. A higher degree of purity and recovery of megakaryocytes was 
obtained with Percoll as compared with BSA. Percoll fraction I, containing cells with 
a  density lower than  1.050 g/cm  a, had  1.51% megakaryocytes, representing a  38-fold 
enrichment  over unseparated  marrow  cells.  The  megakaryocytes recovered  in  this 
fraction accounted for over 90% of the starting sample. Fraction II (d =  1.050 g/cm  3) 
contained only a  minor proportion  (<5%) of the megakaryocytes. 
Among unseparated  megakaryocytes, ~  90%  excluded  trypan  blue  dye.  Of those 
that  took up  the  dye  (8-17%),  two  recognizable  groups were observed.  In the  first 
group  (3-7%),  the  entire  cell,  including  the  nucleus,  was  deeply  stained,  and  cells 
were classified  as nonviable.  In the second group  (5-10%),  cells were stained  with a 
unique  staining  pattern.  This  consisted  of a  very  light,  uniform  staining  of the 
cytoplasm. The nucleus  did  not  take  up  the  dye, and  the  viability of this  group of 
cells  was  difficult  to  determine.  Both  groups  of dye-stained  megakaryocytes  were 
denser  than  1.085 g/cm  a BSA and  yet were found in  the  lowest  density  fraction  in 
Percoll (fraction I). 
When  cell  integrity  was  assessed  by  phase  microscopy,  most  of  the  purified 
megakaryocytes were observed to have a normal birefringent membrane pattern, and 
cytoplasmic degranulation was present  only in about 3-5% of separated  megakaryo- 
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TABLE I 
Purification of Human Marrow Megaka~yocytes by Density Centrifugation and Velocity Sedimentation 
Medium  Yield 
Cell suspension  density 
Megakaryocytes 
Number x 
10  a  Percent* 
Purity  Enrichment:]:  Viability 
Unseparated  marrow 
cells 
After BSA gradient cen- 
trifugation 
Fraction I 
Fraction II 
Fraction III 
After  Percoll gradient 
centrifugation 
Fraction I 
Fraction II 
Fraction III 
After  velocity sedimen- 
tation  of  Percoll 
fraction I 
I cycle:Pellet 
2 cycle:Pellet 
g/cm 3  %  % 
180 +  80§  100  0.04 :t: 0.02  84 ±  10 
<1.062  90 ±  5  50±  13  0.40± 0.16  9.5 ±  1.2  99 ±  1 
1.062  22 ±  1  12 ±  3  0.08 ±  0.06  2 +  0.1  99 ±  1 
>1.062  68 ::l: 4  38 +  5  0.02 +  0.01  0.5 ±  0.1  35 ::t: 10" 
<1.050  169:1:5  94:t: 2  1.51 ±  0.32  38±  10  92 +  5 
1.050  9+  1  5 ±  1  0.02 ±  0.01  0.5 +  1  99 +  1 
>1.050  0  0 
150:1: 10  90 +  5  33.4 +  10.5  835 +  210  93 ±  5 
148::1: 8  89± 4  85:1: 13  2125::1:  250  93 +  3 
* Percent recovery from unseparated marrow cells. 
Fold enrichment over unseparated marrow cells. 
§ Mean values and SD of at least 12 experiments for each separation procedure. 
Further  Purification  of Human  Marrow  Megakaryocytes  by  Velocity  Sedimentation.  For 
greater purification of megakaryocytes, marrow cells harvested from Percoll fraction 
I  were  processed  by  velocity sedimentation. Optimal  separation  was  obtained by 
centrifuging the cells in a  2-4% Ficoll gradient at  100 g  for 5 min (Fig. 2). The vast 
majority of megakaryocytes were found in the pellet, the fastest sedimenting fraction, 
together  with  only  1-3%  of  the  other  marrow  cells.  The  results  of  purification 
experiments of human megakaryocytes by sequentially processing marrow samples 
through Percoll gradient centrifugation and velocity sedimentation in Ficoll are given 
in Table I. After two sedimentation cycles, purity was increased to 2,125-fold (range: 
1,500-4,000) over the unseparated sample, and megakaryocytes represented --- 85% of 
the total cells. Overall, ~  150,000 megakaryocytes were isolated from each marrow 
sample, representing over 90% of the starting megakaryocyte population (Fig. 3 and 
4). 
Identification  of Platelet-Associated  Components  in  Isolated Megakaryocytes.  Various cell 
components known to be associated with platelets were investigated in isolated human 
megakaryocytes by  immunofluorescence (Table  II).  Fibrinogen, factor  VIII:AGN, 
platelet myosin, and platelet glycoproteins I and III were detected on the membrane 
and  in  the  cytoplasm  of  most  of  the  marrow  megakaryocytes.  The  pattern  of 
membrane staining for the various antigens consisted of fluorescent spots and patches 
evenly distributed over the entire cell (Fig. 5). These patterns very much resembled 
those described on leukocytes for other surface antigens such as surface Ig, H2 antigens, 
and leukemic membrane-associated antigens (31,  39,  40).  Several technical aspects I00 
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Fro.  2.  Sedimentation profile of Percoll fraction I cells after velocity sedimentation in a 2-4% 
Ficoll gradient at 100 g for 5 min. Columns (shaded: megakaryocytes,  open: other types of marrow 
nucleated cells) represent the mean percent of total cells recovered from a typical experiment in 
which the yield was > 90% of the starting cells. M, gradient meniscus; B, gradient bottom. 
were of importance in showing the specific presence of these membrane antigens on 
megakaryocytes. First, it was crucial that the megakaryocytes were viable at the time 
of reaction with the fluoresceinated conjugate. Live megakaryocytes, when stained for 
membrane  components,  did  not  show  nonspecific  fluorescence  and  exhibited  no 
"background" reaction. Dead megakaryocytes obtained after hypotonic shock reacted 
nonspecifically with all fluorescein-conjugated antibodies.  The reaction of the dead 
cells  was  homogeneous  and  could  thereby  be  differentiated  from  the  reactions 
exhibited by the live megakaryocytes. More importantly, the antibodies used to detect 
megakaryocyte-associated antigens  were  antibody  preparations  free  of reactive  Fc 
regions, as human megakaryocytes were shown to express membrane receptors for the 
Fc portion  of IgG (see  below).  The  antibody  preparations  included  either  pepsin- 
derived F(ab')2 fragments or whole IgG antibody treated with S.  aureus protein A that 
binds to and inactivates the Fc portion of IgG molecules. Except for some monocyte 
macrophages that  stained  with  antifibrinogen  reagents and  a  few myeloblasts that 
stained with the anti-Ia serum, megakaryocytes were the only marrow cell type stained 
with all of the various antisera tested. After acetone fixation of megakaryocytes, the 
immunofluorescence reagents produced  a  homogenous staining of cytoplasmic com- 
ponents (Fig. 5). 
Because primate and nonprimate platelets had been previously examined  for the 
expression of immunologic receptors and antigens, human and mouse megakaryocytes 
were studied  in parallel for these surface markers (Table III). IgG-FcR, Ia antigens, 
and  two different  types of complement receptors  (CRI and  CR2)  were detected  by 
immunofluorescence and  (or) rosette assay techniques.  FcR were found on over 90% 
of isolated human megakaryocytes with either fluoresceinated antigen-antibody com- 
plexes or IgG antibody-sensitized ox erythrocytes. Ia antigens were demonstrated on 
only  10-15% of isolated human megakaryocytes and, significantly, were not present 
on platelets. By contrast, FcR and Ia antigens were not detected on freshly isolated or 
cultured murine megakaryocytes. Human megakaryocytes were devoid of complement 
receptors, whereas mouse megakaryocytes expressed CR1 but not CRz. Both human RABELLINO, NACHMAN, WILLIAMS, WINCHESTER,  AND  ROSS  1281 
FIG.  3.  Human marrow megakaryocytes  separated by Percoll  density centrifugation followed by 
two  velocity sedimentation  cycles  in  Ficoll.  Isolated  megakaryocytes  (95% megakaryocytes,  3% 
myeloid cells, 2% erythroid cell precursors)  under phase contrast microscopy  (×  125, photographic 
field of 1.4-mm diagonal). 
and mouse megakaryocytes  did not express detectable surface-bound immunoglobulin 
(surface  Ig).  Studies of platelets and their homologous megakaryocytes revealed a 
parallel expression of FcR, and complement receptors.  (Table III). 
Discussion 
Our studies demonstrate that human megakaryocytes contained several  platelet- 
associated coagulation and membrane proteins that are of paramount importance for 
the functional role of platelets during coagulation and hemostasis. In addition, studies 
of certain  differentiation markers  such  as  FcR,  C  receptors,  and  Ia  antigens on 
megakaryocytes and platelets indicate that these membrane receptors  may be useful 
for monitoring events of megakaryocyte maturation. 
These studies were facilitated by the development of a method for isolating highly 
purified populations of human bone marrow megakaryocytes with almost 90% yield. 
Highly purified populations of megakaryocytes were obtained by a combination of 
density centrifugation and  velocity sedimentation. Megakaryocytes were  heteroge- 1282  CHARACTERIZATION  OF  HUMAN  MEGAKARYOCYTES 
Fro.  4.  Purified human marrow megakaryocytes stained with Wright-Giemsa.  ×  788. RABELLINO,  NACHMAN, WILLIAMS, WINCHESTER,  AND  ROSS 
TABLE II 
Detection of Platelet-Associated Cell Components in Human Megakaryocytes  by 
Immunofluorescence 
Components 
Percent of megakaryocytes stained 
Membrane  Cytoplasm 
Fibrinogen  90 +  5*  91  ±  3 
Factor VIII:AGN  80 +  8  10 ±  4 
a2-Macroglobulin  0  0 
Platelet-myosin  87  ±  2  90  ±  5 
Platelet glycoprotein I  98 ±  1  98  ±  1 
Platelet glycoprotein III  97  ±  2  97:1:2 
* Mean value of percent and 1 SD of at least eight experiments. 
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Fio.  5.  Immunofluorescent  staining pattern of isolated human megakaryocytes. Membrane-asso- 
ciated fibrinogen, (a) rim pattern of evenly distributed fluorescent spots, (b) patchy staining pattern. 
Cytoplasmic staining of platelet glycoprotein III, (c) homogeneous staining pattern after fixation of 
megakaryocyte in acetone. 
neous in the density properties when  BSA was used as the separation medium. This 
diversity in cell density may reflect the development of increased nuclear ploidy and 
production of cytoplasmic elements, including formation of dense granules. Alterna- 
tively, the density properties may reflect the unique characteristics of the demarcation 
membrane  system  that  is contiguous  with  the  outer  membrane  of megakaryocytes 
(41).  With  such  a  system,  it  might  be  anticipated  that  these  cells  might  take  up 
variable amounts  of the density medium and  thus  become differentially sensitive to 
centrifugation forces. 
Percoll is a  separation medium that  does not penetrate cells, even after loss of cell 
membrane  permeability (21).  Advantage of this property was taken for the isolation 
of megakaryocytes, as only the salt solution in the separating medium would be taken 
up  and  subsequently  influence the cell density. When  separation was  performed  in 
this medium, all megakaryocytes were much  less dense than other marrow cells. It is 
of note  that  the  density distribution of all the  other  types of marrow  cells was  not 
appreciably  different  when  the  two  different  types  of  density  media  were  used. 
Because of the special behavior of megakaryocytes in Percoll, it can not be assumed 
that  buoyant density distributions of these cells will be similar with other separation 
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TABLE III 
Membrane Markers on Human and Mouse Megakaryocytes  and Platelets 
Marker 
Percent of cells bearing membrane markers 
Human  Mouse 
Megakaryo-  Platelets  Megakaryo-  Platelets 
cytes  cytes 
FcR  95 ±  3*  85 +  3  <0.5  0 
Surface Ig  <0.1  0  <0.5  0 
CR~:~  <0.1  0  25 +  10  3 +-.  l 
CRY§  <0.1  0  <0.5  0 
Ia antigen  15 ±  8  0  <0.5  0 
* Mean value of percent and l SD of at least six experiments. 
:~ CR1 was assayed with EAC complexes  containing purified human C4b and EAC complexes 
containing mouse C3 in its C3b form on human and mouse cells, respectively. 
§ CR2 was assayed with EAC complexes containing human C3 in its C3d form and EAC 
complexes containing mouse C3 in its C3d form on human and mouse cells, respectively. 
The  fact  that  fibrinogen,  factor VIII:AGN, platelet  glycoproteins  I  and  III, and 
platelet  myosin were detected on the membrane and in the cytoplasm of over 90% of 
megakaryocytes suggested that  these platelet-related  molecules are intrinsically  asso- 
ciated with megakaryocytes, and their appearance may occur during the early stages 
of  megakaryocyte  development.  It  is  known  that  various  platelet  disorders  are 
associated  with  selective  protein  abnormalities.  These  include  Bernard  Soulier's 
disease  (human platelet  glycoprotein Ib and  Is deficiency), thrombasthenia  (human 
platelet  glycoprotein IIb and  IIIa deficiency),  von Willebrand's  disease  (some  types 
with  absent  platelet  VIII:AGN), and  afibrinogenemia  (detectable  but  low  platelet 
fibrinogen)  (42-44). Thus, the study of the synthetic function of isolated megakaryo- 
cytes from such patients  may help elucidate  the nature  of the cellular abnormalities 
involved in these various disorders. 
Parallel  studies  of megakaryocytes and  platelets  from human  and  mouse sources 
revealed  that  there  were  differences  in  the  expression  of FcR  and  two  types  of C 
receptors. A proportion of human megakaryocytes, but not homologous platelets, bore 
the  Ia antigen,  indicating  that  the expression  of this  marker  may be  restricted  to a 
subclass  of megakaryocytes. This  latter  type of cell  may represent  a  more primitive 
megakaryocyte class similar to those early cells expressing Ia antigen  in the gra,lulo- 
cytic and erythroid series (45, 46). Alternatively, this megakaryocyte class may reflect 
the  development  of separate  megakaryocyte  lineages,  with  subsequent  restricted 
platelet  functions  (19,  20).  Heterogeneity  in  the expression  of membrane-associated 
differentiation  markers  has  also  been  observed  with  mouse  megakaryocytes.  Our 
studies demonstrated that 30% of mouse megakaryocytes expressed CRt along with a 
proportion of blood platelets,  indicating that this receptor may be acquired at a  late 
stage of development  (17,  47).  It is  anticipated  that  analysis  of the acquisition  and 
loss  of membrane  and  cytoplasmic  components  on  highly  purified  megakaryocyte 
populations will provide further knowledge of the mechanisms of platelet  production 
and  the  events  of platelet  release.  Furthermore,  the  availability  of highly  purified 
populations of megakaryocytes maintained  in culture should help define the microen- 
vironmental conditions that influence the processes of thrombopoiesis. RABELLINO,  NACHMAN,  WILLIAMS, WINCHESTER, AND  ROSS  1285 
Summary 
Human marrow megakaryocytes have been isolated with high purity and yield by 
processing  marrow  cells  sequentially  through  density  centrifugation  and  velocity 
sedimentation. Analysis of the isolated cells for various platelet-assoeiated components 
by  immunofluorescence  demonstrated  that  fibrinogen,  plasma  factor VIII antigen 
(factor VIII:AGN) platelet  myosin, platelet  glycoproteins I and III are present on the 
membrane  and  in  the  cytoplasm  of over 90%  of marrow  megakaryocytes.  Parallel 
studies  of human  and  mouse megakaryocytes and  platelets  for IgG receptor  (FcR), 
complement receptor type one (CR1)  (C3b receptor), complement receptor type two 
(CR2)  (C3d  receptor),  and  Ia  antigen  by  fluorescence  and  (or)  rosette  formation 
methods  were  performed.  FoR  were  present  on  most  human  megakaryocytes  and 
platelets.  The  Ia antigen  was  detected  on  a  proportion  (10-15%)  of human  mega- 
karyocytes but it was undetectable on human platelets.  CR1 was found on 20-40% of 
mouse megakaryocytes and also on a proportion of mouse platelets. These differentia- 
tion markers may be of use in monitoring megakaryocyte maturation. 
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